Janssen Pharmaceutica, N.V. v. Mylan Pharmaceuticals, Inc.
1:15-cv-00760
Overview
Parties
Plaintiff
Gilead Sciences Ireland UC Operating Company
Represented By
3 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Farnan LLP
919 North Market Street, 12th Floor
Janssen Pharmaceutica, N.V. NPE (Individual / Inventor)
Represented By
9 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Janssen Sciences Ireland UC Operating Company
Represented By
3 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Intervenor
Gilead Sciences, Inc. Operating Company
Represented By
6 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Farnan LLP
919 North Market Street, 12th Floor
Counter Claimant
Mylan Inc. Operating Company
Represented By
2 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Devlin Law Firm
1526 Gilpin Avenue, 19806
Mylan Pharmaceuticals, Inc. Operating Company
Represented By
6 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Devlin Law Firm
1526 Gilpin Avenue, 19806
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 16 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 8 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8841310
Combinations of a pyrimidine containing NNRTI with RT inhibitors
|
Filed: 2009-10-07
Issued: 2014-09-23
|
Expired (Term Ended)
Expires: 2025-12-09
|
|
|
US7125879
HIV inhibiting pyrimidines derivatives
|
Filed: 2002-08-09
Issued: 2006-10-24
|
Expired (Term Ended)
+1234d PTA
Expires: 2025-12-25
|
|
|
US8101629
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
|
Filed: 2010-07-28
Issued: 2012-01-24
|
Active (3.7 yrs remaining)
Expires: 2030-07-28
|
|
|
US7399856
Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-2pyrimidinyl]amino]benzonitrile
|
Filed: 2003-08-07
Issued: 2008-07-15
|
Expired (Term Ended)
Expires: 2023-08-07
|
|
|
US7563922
Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
|
Filed: 2007-04-23
Issued: 2009-07-21
|
Expiring Soon (154 days)
Expires: 2027-04-23
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
71
Dispositive
35
Granted
2
Denied
0
Pending / Review
49
Motions by Category
Key Dispositive Motions & Rulings